REV Group CFO bought $136,350 in company shares, while Neurocrine Biosciences CEO sold $34M in company shares Welcome to "Fly Insider," The Fly's weekly recap of notable insider stock transactions.
NOTABLE INSIDER PURCHASES: Significant insider purchases reported in the prior week from January 11 through January 15 include:
- CFO of REV Group (REVG) Mark Skonieczny purchased 15,000 shares of company stock for $9.09 per share for a total consideration of $136,350
- Chairman of Cryo-Cell (CCEL) David Portnoy purchased 15,500 shares of company stock for $7.97 per share per share for a total consideration of $123,555
- VP of Steel Partners Holdings (SPLP) Gordon Walker purchased 70,182 shares of company stock for $11.11 per share per share for a total consideration of $779,533
- Chairman of Riley Financial (RILY) Bryant Riley purchased 100,000 shares of company stock for $46.00 per share for a total consideration of $4,600,000
NOTABLE INSIDER SALES: Significant insider sales in the prior week from January 11 through January 15 include:
- CEO of Facebook(FB) Mark Zuckerberg sold 44,750 shares of company stock for $253.40 per share per share for a total consideration of $11,339,663
- CEO of Neurocrine Biosciences (NBIX) Charles Gorman sold 308,250 shares of company stock for $110.22 per share per share for a total consideration of $33,973,866
- Chairman of 1Life Healthcare (ONEM) Dan Rubin sold 185,457 shares of company stock for $41.23 per share for a total consideration of $7,646,262
- CFO of Adaptive Biotechnologies (ADPT) Chad Cohen sold 50,000 shares of company stock for $63.41 per share for a total consideration of $3,170,270.
NOTABLE PRICE MOVEMENT AFTER INSIDER TRANSACTION: Shares of REV Group are up 17% since Mark Skonieczny purchased 15,000 shares, while shares of Neurocrine Biosciences are down 2% since Charles Gorman sold 308,250 shares.
Symbols:
ADPT REVG CCEL SPLP RILY FB - $261.66 /
+10.13 (+4.03%)
NBIX ONEM - $47.03 /
+4.385 (+10.28%)
Keywords: insider trading, insider buying, insider selling, executive trading, executive buying, executive selling, stock transactions, SEC